If you’ve noticed your child struggling with handwriting, you’re not alone. Researchers have made a groundbreaking discovery that could change the way we understand and address dysgraphia, a writing disorder that affects millions of children worldwide.
What is Dysgraphia?
Dysgraphia is a neurological disorder that affects an individual’s ability to write, primarily due to difficulties with handwriting, spelling, and composition. It is one of the three core subgroups of Specific Learning Disorder (SLD), alongside dyslexia and dyscalculia.
New study reveals biochemical clues to dysgraphia! Researchers found elevated levels of AGMAT in children with SLD. What does this mean for diagnosis and treatment?
The Study’s Findings
A recent study published in the journal MDPI found that children with SLD had significantly elevated levels of agmatinase (AGMAT) compared to neurotypical controls. This enzyme is involved in the degradation of agmatine, a neurotransmitter that plays a crucial role in various physiological processes.
Dysgraphia is not just a matter of poor handwriting, but a complex condition that affects an individual’s ability to express themselves in writing.
Laura Lurns · Learning Success expert
Implications and Future Directions
The study’s findings have significant implications for the diagnosis and treatment of dysgraphia. By identifying biochemical markers such as AGMAT, researchers may be able to develop more effective diagnostic tools and therapies to help children with dysgraphia overcome their writing difficulties.
Key takeaways
- Dysgraphia: a neurological disorder that affects writing abilitiesAGMAT: an enzyme involved in agmatine degradation, found to be elevated in children with SLDDiagnostic potential: biochemical markers like AGMAT may aid in dysgraphia diagnosis
What Parents Can Do
While the study’s findings are promising, it’s essential for parents to remember that dysgraphia is a complex condition that requires a comprehensive approach to treatment. By working with educators, therapists, and healthcare professionals, parents can help their child develop the skills and strategies needed to succeed in writing and other areas of academics.
By understanding the biochemical mechanisms underlying dysgraphia, we can work towards developing more effective treatments and therapies to help children overcome their writing difficulties. The Learning Success All Access Program offers a comprehensive approach to addressing dysgraphia, with personalized action plans and expert guidance. Start your free trial today and help your child unlock their full potential.
See what All Access gives your child
Take the dysgraphia test
Is your child struggling in school?
Get your free personalized learning roadmap
You describe what you see at home. We turn it into a plan you start this week.
- Answer 5 short questionnaires about what you already notice, 30–45 minutes at your own kitchen table
- Your child sits no test and gets no score: nothing to schedule, nothing for them to dread
- You do the answering, the AI does the writing, and a person reviews it before it reaches you
- Access all 40+ courses instantly: reading, math, focus, processing and more, with new ones added regularly
Why we use AI, plainly: it writes from a knowledge base our team maintains and audits. We work through it line by line and pull anything the evidence stops supporting. The roadmap you get on Tuesday reflects what we corrected on Monday, and a human still reads it before you do.
Your school district must evaluate your child free of charge if you ask in writing, whatever your income and whatever the outcome (US, 34 CFR 300.111 and 300.301(b)). That route takes time and answers a different question than you do. This one starts today, from what you already know.
Your answers stay yours. We do not sell your personal information, and we do not hand identifiable assessment data to outside AI companies to train their models.
A screener is a starting point, not a diagnosis. If your child might need formal accommodations (an IEP or 504 plan), or you suspect a vision, hearing or medical cause, pursue a professional evaluation too. That is the only route to those supports.
References
- MDPI - Journal Article
